Eli Lilly

Takeda Hid Diabetes Medicine’s Cancer Risks, Jury Is Told
Bloomberg
Mon, 05/19/14 - 03:25 pm
Takeda
diabetes
Actos
Eli Lilly
Mergers seem to be a prescription for growth for pharmaceuticals
Yahoo/Market Realist
Thu, 05/15/14 - 05:59 pm
M&A
Pfizer
GSK
Merck
Bayer
AstraZeneca
Valeant Pharmaceuticals
Novartis
Eli Lilly
Eli Lilly's necitumumab improves OS in Phase III study
The Fly on the Wall
Thu, 05/15/14 - 08:26 am
Eli Lilly
necitumumab
non-small cell lung cancer
Lilly's diabetes drug as effective as Sanofi's in late-stage trials
Yahoo/Reuters
Mon, 05/12/14 - 09:47 am
Eli Lilly
Sanofi
diabetes
basal insulin peglispro
Lantus
Show me the money: Which drugs made the top 10 list on upfront deals?
Fierce Biotech
Mon, 05/12/14 - 09:36 am
biotech
GED-0301
Celgene
Nogra Pharma
AbbVie
Reata
Bardoxolone
Abbott Labs
Tradjenta
Eli Lilly
Boehringer Ingelheim
FG-4592
AstraZeneca
FibroGen
Pfizer
Bristol-Myers Squibb
Eliquis
Moderna
Forma Therapeutics
dimebon
Medivation
Jakafi
Novartis
Incyte
Lilly Responds to Brazil Court Ruling in Labor Case
Yahoo/PR NewsWire
Sat, 05/10/14 - 10:52 am
Eli Lilly
legal
Eli Lilly and Italian firm fined $450 mln for poisoning in Brazil
Reuters
Sat, 05/10/14 - 10:50 am
Eli Lilly
legal
10 big brands keep pumping out big bucks, with a little help from price hikes
Fierce Pharma Marketing
Wed, 05/7/14 - 03:42 pm
Xyrem
Jazz Pharmaceuticals
Humulin
Eli Lilly
Premarin
Mylan
Lunesta
Sunovion
Benicar
Daiichi Sankyo
Lantus
Sanofi
Viagra
Pfizer
Gleevec
Novartis
Copaxone
Teva Pharmaceuticals
EpiPen
drug pricing
Is Merrimack Pharmaceuticals Worth More Than $700 Million?
Motley Fool
Mon, 05/5/14 - 05:02 pm
Merrimack Pharmaceuticals
pancreatic cancer
MM-398
Gemzar
Eli Lilly
Celgene
Abraxane
Eli Lilly Earnings: What Investors Need to Know
Motley Fool
Sat, 05/3/14 - 11:35 am
Eli Lilly
earnings
6 Drugs That Could Move the Pharma Market
Wall St Cheat Sheet
Wed, 04/30/14 - 12:37 pm
Gilead Sciences
Teva Pharmaceuticals
Copaxone
Idelalisib
Bristol-Myers Squibb
nivolumab
Cyramza
Eli Lilly
Pfizer
palbociclib
Sovaldi
Drug Merger Boom Sends Hedging Costs to Eight-Year High
Bloomberg
Wed, 04/30/14 - 08:39 am
M&A
Gilead Sciences
Forest Labs
Pfizer
Allergan
Eli Lilly
[video] Why Is the Drug Industry in a Deal Frenzy?
Bloomberg
Thu, 04/24/14 - 07:31 am
M&A
Novartis
Valeant Pharmaceuticals
GSK
Eli Lilly
Allergan
Expired Patents Take a Bite out of Eli Lilly Results
Yahoo/247WallStreet
Thu, 04/24/14 - 07:26 am
Eli Lilly
earnings
Earnings Preview: Eli Lilly guidance may be in focus after acquisitions
The Fly on the Wall
Wed, 04/23/14 - 03:05 pm
earnings
Eli Lilly
The Novartis-Glaxo-Lilly Swap’s Downside: Less Research
Bloomberg/Businessweek
Wed, 04/23/14 - 08:42 am
Novartis
Eli Lilly
R&D
GSK
M&A
Novartis, Valeant bids herald new deal-making era for pharma
Yahoo/Reuters
Wed, 04/23/14 - 08:30 am
Novartis
Valeant Pharmaceuticals
GSK
Eli Lilly
M&A
Allergan
With Big Pharma In Retreat, Ackman And Novartis Try A New Blueprint For Drug Companies
Forbes
Tue, 04/22/14 - 09:51 am
Novartis
M&A
GSK
Eli Lilly
Allergan
Valeant Pharmaceuticals
[video] Novartis CEO Says New Purchases Will Boost Sales
Bloomberg
Tue, 04/22/14 - 09:28 am
Novartis
Pharma CEOs
Joe Jimenez
M&A
animal health
Eli Lilly
GSK
vaccines
Novartis Buys Glaxo Cancer Unit for $16B, Sells Animal Health to Eli Lilly for $5.4B
Yahoo/Bloomberg
Tue, 04/22/14 - 07:32 am
Novartis
Joe Jimenez
GSK
animal health
Eli Lilly
vaccines
M&A

Pages